Head-to-head · Cost-Efficiency Index
Goldspan Health vs AHBARx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Goldspan Health
Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Visit Goldspan HealthAHBARx
Shoppers who want one number that already contains the visit fee and the shipping, and who will read the terms before subscribing.
Visit AHBARxThe verdict
Goldspan Health takes it, leading the Cost-Efficiency Index 71 to 70. Goldspan Health sells compounded semaglutide at $229 and tirzepatide at $299 every 28 days, with daily sublingual and low-dose versions of both at lower prices, through a storefront operated by a different company. AHBARx still earns a C — Shoppers who want one number that already contains the visit fee and the shipping, and who will read the terms before subscribing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Goldspan Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Goldspan Health | AHBARx |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 70/100 |
| Semaglutide / mo | $229 every 28 days month-to-month (13 charges a year, not 12) | $249/mo month-to-month (a $50 consultation and $25 shipping are inside the figure) |
| Tirzepatide / mo | $299 every 28 days month-to-month (13 charges a year, not 12) | $349/mo month-to-month (consultation and shipping included in the figure) |
| Semaglutide / yr (modeled) | $2,748 | $2,988 |
| Tirzepatide / yr (modeled) | $3,588 | $4,188 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #77 | #82 |
Goldspan Health
71/100Where the value is
- Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
- Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
- States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
The tradeoffs
- The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
- "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
AHBARx
70/100Where the value is
- Both monthly prices, the $50 consultation and the $25 shipping are itemized on a checkout panel you can reach without an account or an intake
- Names its compounding partner, AnazaoHealth, and its clinical partners, Beluga Health and Qualiphy
- Names a founding physician with credentials on the About page rather than referring only to a network
The tradeoffs
- The terms of service and the privacy policy are unedited templates: they still print "[list of Pharmacies]", "[list of Labs]", "[phone number]" and even "[www.ahbarx.com]" where the company's own details belong
- The About page says there are no membership fees while the terms require "the Weight Loss Membership on an automatically renewing monthly subscription basis" — no membership line appears at checkout, so which one governs is unclear
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.